PROVIDER PROFILE · NPI 1962575357

Samantha Storey

Internal MedicineAtlanta, GAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

201

Beneficiaries

—

Total drug cost

$12K

Distinct drugs

Brand share

7.5%

Top prescribed drugs

Amlodipine Besylate32 claims

Losartan Potassium25 claims

Levetiracetam21 claims

Gabapentin20 claims

Memantine Hcl18 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Samantha Storey's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 33 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
FLOYD HEALTHCARE MANAGEMENT INC	102	209
Richard Donadio Physical Medicine and Rehabilitation · Rome, GA	95	153
Nicole Fobi Nunga Hospitalist · Gainesville, GA	51	98
Shailender Peesapati Internal Medicine · Lawrenceville, GA	41	84
Floyd Healthcare Management Inc Ambulance Service Provider · Rome, GA	41	73
Michael Kizziah Diagnostic Radiology · Rome, GA	34	73
James Moseley Diagnostic Radiology · Rome, GA	33	96
Kevin Phillips Diagnostic Radiology · Rome, GA	31	58
DELMAR GARDENS OF SMYRNA, LLC	30	169
PRUETT, STEVEN	28	71
Joseph Burch Diagnostic Radiology · Rome, GA	27	57
Daniel Valancius Internal Medicine · Allentown, PA	27	65

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history